TMCnet

Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral "Multi-Biologic in a Pill" for Inflammatory Bowel ...

This milestone marks Enveda's third asset to enter clinical development, following ENV-294 (atopic dermatitis and asthma) and ENV-308 (obesity), underscoring the productivity of the company's platform ...
Business Wire

Endeavor BioMedicines Presents New Clinical Findings From Post Hoc Analysis of Phase 2a Clinical Trial Evaluating ENV-101 in Patients with Idiopathic Pulmonary Fibrosis

SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients ...
Business Wire

Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board

BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a biotechnology company using AI to translate nature into new medicines, is proud to announce testing of its lead asset, ENV-294, in a second indication: ...
ZDNet

Botnets have been silently mass-scanning the internet for unsecured ENV files

Drawing little attention to themselves, multiple threat actors have spent the past two-three years mass-scanning the internet for ENV files that have been accidentally uploaded and left exposed on web ...
CNET

The first amazing LG phone (at least for me)

For one CNET editor, the long road that led to LG's new and promising G3 dates back almost 10 years ago to the still-excellent LG EnV. Kent was a senior managing editor at CNET News. A veteran of CNET ...
CSOonline

AWS environments compromised through exposed .env files

Attackers collected Amazon Web Services keys and access tokens to various cloud services from environment variables insecurely stored in tens of thousands of web applications. A data extortion ...